Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$52,706,556
+$8,362,605 QoQ
Shares Held
43,943
-8.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#535
of 4,605 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Metis Global Partners, LLC holds $140,227,316 across 10 Drug Manufacturers - General names. LLY ranks #1 (37.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
43,943 | $52,706,556 | |
| 2 | JNJ |
Johnson & Johnson
|
93,168 | $23,661,876 | |
| 3 | ABBV |
AbbVie Inc.
|
82,938 | $20,870,518 | |
| 4 | MRK |
Merck & Co., Inc.
|
102,719 | $13,199,391 | |
| 5 | AZN |
Astrazeneca PLC
|
46,633 | $8,842,549 | |
| 6 | AMGN |
Amgen Inc
|
17,289 | $6,260,692 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
43,024 | $5,435,652 | |
| 8 | PFE |
Pfizer Inc
|
181,310 | $4,365,944 |
All Filings in LLY
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $52,706,556 | 43,943 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $44,343,951 | 48,212 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $53,630,835 | 49,904 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $39,741,618 | 52,086 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $42,407,211 | 54,401 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $44,060,646 | 53,348 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $37,150,956 | 48,123 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $41,825,227 | 47,210 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $41,739,828 | 46,102 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $36,038,219 | 46,324 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $26,940,813 | 46,217 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $21,960,560 | 40,885 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $16,574,222 | 35,341 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $11,585,273 | 33,735 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $9,274,775 | 25,352 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $4,939,494 | 15,276 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,422,497 | 13,640 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $3,672,695 | 12,825 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $2,078,831 | 7,526 | Shares | Sole | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||